Matthias Bodenstedt
Director of Finance/CFO at MOONLAKE IMMUNOTHERAPEUTICS
Net worth: 41 M $ as of 2024-03-30
Profile
Matthias Bodenstedt is currently the Director and Chief Financial Officer at Moonlake Immunotherapeutics Ltd., Moonlake Immunotherapeutics AG, and MoonLake Immunotherapeutics.
Prior to this, he worked as a Partner at McKinsey & Co., Inc. from 2015 to 2021.
Bodenstedt received his undergraduate degree from the University of Hannover, his graduate degree from the University of Cambridge, and his MBA from Columbia Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-14 | 520,903 ( 0.87% ) | 26 M $ | 2024-03-30 | |
| 2024-03-14 | 294,473 ( 3.29% ) | 15 M $ | 2024-03-30 |
Matthias Bodenstedt active positions
| Companies | Position | Start |
|---|---|---|
| MOONLAKE IMMUNOTHERAPEUTICS | Director of Finance/CFO | 2022-04-04 |
Moonlake Immunotherapeutics AG
 Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The private company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Director of Finance/CFO | 2021-06-30 |
| Moonlake Immunotherapeutics Ltd. | Director/Board Member | 2021-08-31 |
Former positions of Matthias Bodenstedt
| Companies | Position | End |
|---|---|---|
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Corporate Officer/Principal | 2021-05-31 |
Training of Matthias Bodenstedt
| University of Cambridge | Graduate Degree |
| University of Hannover | Undergraduate Degree |
| Columbia Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| MOONLAKE IMMUNOTHERAPEUTICS | Health Technology |
| Private companies | 3 |
|---|---|
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
Moonlake Immunotherapeutics AG
Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The private company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Health Technology |
| Moonlake Immunotherapeutics Ltd. |
- Stock Market
- Insiders
- Matthias Bodenstedt